Martie S Lubbe, Francois N Slabbert, Brian H Harvey and Christiaan B Brink
The importance of pharmacovigilance, now and in the future
Michelle Perry
Sakina Zerizer, Benmebarek A, Laggoune S and Kabouche Z
Giulia Milano
An observational study of cutaneous adverse drug reactions in a teaching hospital
Deepti Chopra, Vibha Sharma, Rohan Kapoor and Shridhar Dwivedi
Naif Al-Hazmi and Naylor I L
Jong Hwan Sung
Martie S Lubbe, Lizane Goossens, Dorcas Rakumakoe, Elzabe Bekker, Ronel van Reenen and Madeeha Malik
The resistance to antimicrobial compounds
Ciuca Alina Maria, Roman Luminta, Ciuca Gheorghe and Mihaescu Grigore
Roman Luminita, Ciuca Alina, Ciuca Georghe and Mihaescu Grigore
Javeria Fazal
Challenge of pediatric pharmacovigilance in tertiary care centre
Princy Louis Palatty, Manjeshwar Shrinath Balliga and Fathima
Virginia Noxon and Charles Bennett
Abel Nhama1,2, Quique Bassat1,3, Sonia Enosse2, Arsenio Nhacolo1, RosAlia Mutemba2, Eva Carvalho4, Eva Naueia2, Esperança Sevene1, Caterina Guinovart1,3, Marian Warsame5, Sergi Sanz3, Abdul Mussa2, Graça Matsinhe2, Pedro Alonso1,3, Armindo Tiago6 and Eusebio Macete1,2
Analysis of off-label use of drugs among pediatric inpatients of a tertiary care teaching hospital
Mangesh Bankar
Nazanin Namazi Sarvestani
Amina Bayazid
Adverse reaction of certain anti-inflammatory drugs
A Hadji, A Merah and H Houamria
Breast cancer and cancer drug safety
Ashok Srivastava, Ramesh Anumolu and Pallavi Dhillon
Anwar Mulugeta, Girmay Medhin, Getnet Yimer and Abebaw Fekadu
PEDIAVEN® AP-HP NOUVEAU NE 2 perfusion related extravasations in a neonatal intensive care unit
Clement Delage
Sleep disorders related to antidepressant drug use
Farhan Ahmad Khan, Kirti Vishwakarma, Vishal P Giri and Chitrak Bansal
The safety of biological medicines for rheumatoid arthritis & their economic consequences
Giannis Papadopoulos1, K Demetzos1, S Markantoni-Kyroudi1 and K Souliotis2
Frequency of adverse events in plateletpheresis donors in regional transfusion centre in North India
Gopal Kumar Patidar, Ratti Ram Sharma and Neelam Marwaha
Role of pharma industries in the improvement of pharmacovigilance system
Graeme Ladds
Hosu Anamaria Delia1, Roman Luminita2, Ciuca Alina2, Ciuca Gherghe2 and Mihaescu Grigore2
Ioan Magyar
Janus Christian Jakobsen1,2, Christian Gluud1, Per Winkel1, Theis Lange3 and Jorn Wetterslev1
Jie Wu
Ka-Chun Cheung
Conception of Ayurveda adverse drug reaction and pharmacovigilance: An overview
Manjunath Ajanal
M Miroddi, Carmelo Sterrantino and Gioacchino Calapai
M Angeles Pinero-Lopez, Pilar Modamio, Cecilia F Lastra and Eduardo L Marino
Marianne Rufiange
Health professional students’ knowledge on pharmacovigilance (PV)
Meri Koluaçik
Maryam Payan, Mohammad Reza Rouini, Nader Tajik, Mohammad Hossein Ghahremani and Reza Tahvilian
Effectiveness of non-conventional humanitarian responses on Ebola outbreak crisis in West Africa
Michel Talla1,3, Ugwu E Chidiebere2, Oluwasogo A Olalubi3, Isatta Wurie4, Jeannetta K Jonhson5, Jeane Y Ngogang6 and Ernest Tambo6
Mohammed Imran
Minoxidil induced hypertrichosis in children
N Guerouaz, K Senouci, M Ait Ourharoui and B Hassam
Saja Al-Marshad
Aida Sefidani Forough
Cytochrome P450: Why the same drugs do not work the same way on everyone?
Stephen Krau
Growth and structure of clinical trials industries in India: A systematic review
Swadhin Mondal
Yunliang Guo, Tingting Wang, Li Zhao, Meizeng Zhang and Haitao Pei
Zahid Manzoor1, Shaukat Hussain Munawar1, Zahid Iqbal1, Imran Ahmad Khan2, Abdul Aziz2 and Hafiz Muhammad Qasim3
Cancer chemotherapy induced adverse drug reactions
Shubhnita Singh and Deepti Chopra